Syed brachytherapy refers to interstitial radiation therapy delivered through the Syed-Neblett template, a perineal device that guides hollow needles into and around pelvic tumors so a radioactive source can treat cancer from the inside. Developed in the 1970s, it remains one of the most widely used interstitial applicators in gynecologic oncology, especially when standard intracavitary devices cannot adequately reach or cover a tumor. The template has gone through design refinements and planning upgrades over the decades, but its core concept, a grid of channels drilled into a plate that sits against the perineum, has stayed remarkably stable.
What the Template Actually Is
The Syed-Neblett template is a flat or slightly concave plate, typically made of acrylic or similar biocompatible material, perforated with an array of evenly spaced holes. Each hole accepts a hollow needle or catheter that a radiation oncologist inserts through the perineum into the pelvic tissue surrounding a tumor. The template’s job is to hold those needles in a fixed geometric arrangement so the radiation source, usually iridium-192, can be delivered to predictable positions within and around the target.
A key advantage of this design is flexibility. Depending on the tumor’s shape and location, the physician chooses which holes to load with needles, effectively customizing the implant geometry for each patient. Early research comparing customized template arrangements to fixed commercial templates found that tailoring the needle pattern to match a tumor’s shape produced more uniform dose distributions and better coverage of the target volume.
One longstanding practical issue with the original design was verifying that needles had not accidentally punctured the bladder or rectum during insertion. A modified version of the template addressed this by allowing the plate to be partially disassembled after the central needles are placed, so the surgeon can perform cystoscopy and rectoscopy to check needle positions before reassembling and completing the implant.1Elsevier / Radiotherapy and Oncology. A new perineal template assembly for high-dose-rate interstitial brachytherapy of gynecologic malignancies This kind of intraoperative quality check has become standard practice at many centers.
When It Is Used Instead of Simpler Applicators
For many cervical cancers, the go-to brachytherapy approach is an intracavitary device such as a tandem and ovoids (also called a Fletcher-type applicator), which slides into the uterine canal and vaginal fornices. That works well when the tumor is relatively small and centered around the cervix. But when tumors are bulky, extend into the vaginal walls or parametrial tissues, or have an irregular shape that a standard intracavitary device cannot conform to, interstitial brachytherapy with a Syed-Neblett template becomes the better option.
A 2024 dosimetric comparison of the Syed-Neblett and tandem-and-ovoid applicators in cervical cancer patients found that the interstitial approach delivered lower doses to the bladder and sigmoid colon without sacrificing tumor coverage. The authors concluded that the Syed-Neblett applicator is a particularly favorable choice when addressing larger tumors.2Brachytherapy. Dosimetric and toxicity comparison between Syed-Neblett and Fletcher-Suit-Delclos Tandem and Ovoid applicators in high dose rate cervix cancer brachytherapy In other words, neither applicator is universally superior; the choice depends on tumor size and geometry.
That said, older data suggests the picture is not straightforward for every stage. A comparison of intracavitary versus interstitial irradiation for cervical cancer found that patients with stage II disease treated with intracavitary radiation had better five-year disease-free survival (about 50% versus 21%) and local control (about 61% versus 32%) than those treated with interstitial approaches. For stage III and IVA disease, no survival difference was detected between the two methods.3Gynecologic Oncology. A comparison of intracavitary versus interstitial irradiation in the treatment of cervical cancer This older study reflects a period before modern image-guided planning, and the finding reinforces the current consensus: intracavitary devices remain preferred when anatomy allows, and the Syed-Neblett template fills the gap for tumors that intracavitary approaches cannot adequately treat.
Vaginal and Vulvar Cancers
The Syed-Neblett template is not limited to cervical cancer. Vaginal and vulvar malignancies, which arise in areas difficult to treat with intracavitary applicators, are among the template’s strongest use cases. These cancers can occur in locations where standard cylinder applicators do not provide enough depth or coverage, and interstitial needles can be arranged to conform to the tumor’s shape more precisely.
In a study of primary and recurrent vaginal cancers treated with high-dose-rate brachytherapy using the Syed-Neblett template, complete response was achieved in 94% of patients, and two-year local control and cause-specific survival were 88% and roughly 83%, respectively. Patients with primary vaginal cancer and those with recurrence who had not received prior radiation achieved 100% crude local control, while those who had previously been irradiated fared worse at 67%.4PubMed Central. High-dose rate brachytherapy for primary or recurrent cancer in the vagina
Vulvar cancers also respond well. A separate study of interstitial brachytherapy in vaginal and vulvar malignancies reported that all patients with vaginal tumors achieved complete local remission after six months, as did about 78% of those with vulvar cancer. The treatment provided good local control without serious delayed side effects in either group.5PubMed. The role of interstitial brachytherapy in the treatment of vaginal and vulvar malignancies
More recently, image-guided brachytherapy using the template has been applied to distal vaginal and vulvar cancers, with external beam radiation to a median dose of 45 Gy followed by brachytherapy delivering an additional 15 to 27.5 Gy. About 28% of patients recurred over a mean follow-up of roughly 21 months, with local recurrence in about 17%.6Journal of Contemporary Brachytherapy. Clinical outcomes of distal vaginal and vulvar cancer treated with image-guided brachytherapy These results reflect the inherent difficulty of distal vulvar tumors, which tend to be more challenging anatomically than upper vaginal lesions.
The Procedure and What Patients Experience
The Syed-Neblett implant is a surgical procedure performed under anesthesia, typically spinal or epidural, sometimes general. The patient is positioned in lithotomy (legs up, similar to a gynecologic exam), and the physician inserts needles through the perineal template into the tissues surrounding the tumor. The number of needles varies widely depending on tumor size, from a handful to 20 or more. Imaging guidance, whether ultrasound, fluoroscopy, or CT, helps the physician verify needle positions during insertion.
Three-dimensional transvaginal ultrasound is an emerging guidance tool. In a clinical implementation study, radiation oncologists agreed that 3D transvaginal ultrasound improved both implant and anatomy visualization compared to standard two-dimensional ultrasound, with patients whose tumors sat below the upper vagina being particularly well-suited for this technique.7PubMed. Clinical implementation of 3D transvaginal ultrasound for intraoperative guidance of needle implant in template interstitial gynecologic high-dose-rate brachytherapy
After the needles are placed, patients are admitted to the hospital. The template and needles stay in place overnight while one or two additional high-dose-rate radiation treatments are delivered the next day, spaced at least six hours apart. During this period, strict bed rest is required, and pain management is a priority. A continuous epidural, sometimes supplemented with systemic opioids and other pain medications, is often needed to keep patients comfortable while the hardware remains in place. Once the final treatment fraction is delivered, the applicators are removed and pain requirements drop quickly. Most patients are discharged home the same day.8Journal of Contemporary Brachytherapy. Optimal perioperative anesthesia management for gynecologic interstitial brachytherapy
Complications and Safety Profile
Any procedure that pushes needles through the perineum and into pelvic tissue carries risk, and the Syed-Neblett implant is no exception. The most worrisome potential complication during insertion is accidentally puncturing the bladder or rectum with a needle. However, a study examining patients with documented visceral puncture found that these events were surprisingly well-tolerated. Among patients whose bowel was punctured, none developed moderate or worse acute gastrointestinal toxicity, and only one experienced a late severe complication. Among those with bladder puncture, none had more than mild acute genitourinary toxicity, and only two developed late severe genitourinary toxicity.9International Journal of Radiation Oncology • Biology • Physics. Toxicity associated with bowel or bladder puncture during gynecologic interstitial brachytherapy The takeaway is that while puncture is not desirable, it does not inevitably lead to serious harm.
This relatively reassuring modern data stands in contrast to earlier experience. One of the earlier published series of Syed-Neblett cases reported complications in 42% of patients, including severe rectal stricture or rectovaginal fistula requiring surgical diversion in about 22% and hemorrhagic proctitis in about 18%.10PubMed Central. The Syed-Neblett interstitial template in locally advanced gynecological malignancies Those rates reflect the learning curve and the higher total doses used in the early era of the technique. As centers gained experience, adopted image guidance, and refined dose planning, serious complications became much less common. The gap between early and modern complication rates is one of the clearest demonstrations of how technique evolution matters in brachytherapy.
How Treatment Planning Has Evolved
In the early decades of Syed-Neblett brachytherapy, treatment planning was relatively crude. Needle positions were identified on orthogonal X-ray films, and doses were calculated using simple geometric rules. The introduction of CT-based and later MRI-based planning in the 1990s and 2000s transformed the field, enabling physicians to see the actual tumor and surrounding organs in three dimensions and to optimize the dose distribution accordingly.
Modern planning for Syed-Neblett implants typically uses inverse planning algorithms, where the computer determines the optimal dwell times for the radioactive source at each position along each needle. In a review of 43 women treated with high-dose-rate interstitial brachytherapy using the Syed-Neblett template and inverse planning, the clinical target volume received excellent coverage, with a median of about 98% of the target receiving the full prescription dose.11PubMed. Inverse-planned gynecologic high-dose-rate interstitial brachytherapy: clinical outcomes and dose-volume histogram analysis
Researchers have continued to refine optimization methods. A comparison of advanced optimization algorithms for Syed-Neblett cervical cancer plans found that plans using biological dose objectives (rather than purely physical dose targets) achieved better dose homogeneity within the tumor, reduced the overdose index, and lowered the estimated risk of rectal complications.12PubMed. Optimization for high-dose-rate brachytherapy of cervical cancer with adaptive simulated annealing and gradient descent A separate dosimetric study comparing multiple optimization techniques for interstitial cervix implants found that volume-based optimization with isodose reshaping produced the best balance of tumor conformity, homogeneity, and normal-tissue sparing.13PubMed Central. Dosimetric comparison of various optimization techniques for high dose rate brachytherapy of interstitial cervix implants In practice, most centers now use some form of inverse planning followed by manual adjustments, reflecting the reality that no single algorithm produces a perfect plan for every patient’s anatomy.
Cost and Access Challenges
One underappreciated barrier to Syed-Neblett brachytherapy is cost. The template itself can run up to $30,000 based on manufacturer quotes, and the total procedure cost, including the operating room, anesthesia, inpatient stay, and multiple treatment fractions, adds up quickly. A cost analysis comparing the Syed-Neblett template to a novel 3D-printed alternative applicator estimated total implementation costs of roughly $47,400 for the Syed-Neblett approach versus about $16,800 for the 3D-printed device.14PubMed Central. A 3D-Printable, Low-Cost Obturator for Less Invasive Gynecologic Brachytherapy
These numbers matter most in resource-limited settings. Cervical cancer disproportionately affects women in low- and middle-income countries, where access to brachytherapy equipment and expertise is already scarce. If cheaper, 3D-printable applicators can deliver comparable dose distributions, they could bring interstitial brachytherapy to facilities that currently cannot afford Syed-Neblett hardware. That said, these alternatives are still in early development and have not yet been validated in large clinical trials.
Hybrid Applicators and Where the Template Fits Today
The brachytherapy landscape has expanded significantly since the Syed-Neblett template was introduced. Hybrid applicators, such as the Vienna applicator and the Utrecht applicator, combine an intracavitary tandem with a small number of interstitial needles that pass through a ring or ovoid component. These devices are designed to treat cervical tumors with parametrial extension without requiring a full perineal template implant, and they have become popular at academic centers with access to MRI-guided planning.
Hybrid applicators occupy a middle ground: they handle tumors that are too large or asymmetric for a standard tandem-and-ovoid but not so extensive that a full Syed-Neblett implant is needed. For very bulky tumors, tumors involving the lower vagina, or tumors recurring in previously irradiated fields, the Syed-Neblett template still offers the most versatile needle coverage. The choice between a hybrid applicator and a full template implant usually comes down to tumor extent and institutional expertise.
Another consideration is the skill required. Placing a Syed-Neblett implant involves surgical needle insertion under anesthesia, intraoperative imaging, and an overnight hospital admission with intensive pain management. Hybrid applicators are often placed in a single session with a shorter recovery. For centers that perform only a small number of interstitial cases per year, maintaining the procedural skill and support infrastructure for Syed-Neblett implants can be challenging, which nudges some institutions toward hybrid devices for intermediate-complexity tumors.
Common Misconceptions About Interstitial Brachytherapy
Patients sometimes confuse interstitial brachytherapy with external beam radiation, assuming the Syed-Neblett procedure involves lying under a large machine. In reality, the radiation source is a tiny pellet that travels through the implanted needles and pauses at programmed positions, delivering radiation from millimeters away from the tumor. The treatment room may have an afterloader machine in it, but the patient does not feel the radiation itself. What patients feel is the pressure and discomfort of the needles and template, which is why effective anesthesia and analgesia are so important.
Another misconception is that interstitial brachytherapy is a last resort. While it is true that a standard intracavitary device is tried first when anatomy permits, the Syed-Neblett approach is not a second-rate fallback. For tumors with the right characteristics, particularly bulky or irregularly shaped cancers, it delivers superior dose coverage to the target while sparing surrounding organs. The perception of interstitial brachytherapy as inferior likely stems from the fact that it is used in more advanced or difficult cases, which inherently carry worse baseline prognoses regardless of treatment method.
Finally, some patients worry that having needles left in place overnight poses a serious infection or bleeding risk. Modern perioperative protocols, including prophylactic antibiotics and careful hemostasis during needle placement, keep these risks low. The overnight stay is primarily for delivering the remaining radiation fractions and managing pain, not because the hardware itself is especially dangerous. Most patients have the template removed the day after placement and go home the same day with minimal lingering discomfort.